Dublin financiers plan medtech AIM listing
Raglan Capital has teamed up with Irish healthcare and life-science veterans to launch a new company, Horizon Medical Technologies, and plans to float it on London’s AIM stock exchange by the end of the year.
The Dublin-based corporate financiers plan to target acquisitions in the medical technology sector valued at €5 million to €20 million.
Harry Keenan, previously general manager of UK and Ireland at Baxter International, and Joey Mason, a former partner at Delta Partners who has previously worked in finance and business development with Morgan Stanley and Biotrin, are both working on the new project.
Dave Shanahan, former managing director of Pfizer Healthcare Ireland and head ...
